Policy update extends coverage to more than 39 million lives The NeuroBlate® System utilizes robotically controlled laser thermal therapy that directs the MR-guided laser to ablate tissue in the brain ...

PLYMOUTH, Minn., Oct. 18, 2016 /CNW/ -- Monteris Medical today announced that leading surgeons at 40 sites across the U.S. and Canada have used the company's NeuroBlate ® System, a minimally invasive ...

Results and case study findings presented at the 2015 Congress of Neurological Surgeons (CNS) Annual Scientific Meeting Monteris Medical today announced recent data demonstrating that newly diagnosed ...

PLYMOUTH, Minn., Nov. 29, 2018 /PRNewswire/ -- Monteris Medical, the leader in image-guided laser interstitial thermotherapy (LITT), is pleased to announce that health insurance provider Aetna has ...

PLYMOUTH, Minn.--(BUSINESS WIRE)--Monteris Medical today announced the recent completion of a Series C financing, raising $26.6 million in new equity. Monteris Medical is a privately held leader in ...

Analysis demonstrates that NeuroBlate followed by pembrolizumab is safe, well-tolerated and delivers more than a threefold overall survival advantage compared to surgery or biopsy plus immunotherapy ...

MINNEAPOLIS--(BUSINESS WIRE)--Monteris® Medical announced today that the U.S. FDA has issued a second 510(k) clearance for their MRI-guided ablation device for brain tumors and other lesions. The ...

Evidence for NeuroBlate marks the first peer-reviewed long-term data on LITT for drug-resistant epilepsy and establishes the technology as a standard surgical option for most common form of the ...

ST. LOUIS PARK, Minnesota, Nov. 9-- Medical Alley posted the following partner news release from Monteris Medical: MINNETONKA, Minn. - Monteris Medical, the leader in minimally invasive image-guided ...

PLYMOUTH, Minn., May 5, 2020 /PRNewswire/ -- Monteris Medical, the leader in image-guided laser interstitial thermotherapy (LITT), announced today that it has reached a significant milestone: surgeons ...